25 Jan 2024
Hybridan Small Cap Feast - 25 Jan 24
SkinBioTherapeutics Plc (SBTX:LON), 9.8 | Rosslyn Data Technologies PLC (RDT:LON), 1.8 | Petards Group plc (PEG:LON), 9.5 | Petards Group plc (PEG:LON), 9.5 | Novacyt SAS (NCYT:LON), 42.2 | Neometals Ltd (NMT:ASX), 0 | Neometals Ltd (NMT:ASX), 0 | Kromek Group Plc (KMK:LON), 8.8 | Jadestone Energy PLC (JSE:LON), 33.5 | Tissue Regenix Group plc (LSW:STU), 0
25th January 2024
@HybridanLLP
Status of this Note and Disclaimer
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment obje ....
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Hybridan Small Cap Feast - 25 Jan 24
SkinBioTherapeutics Plc (SBTX:LON), 9.8 | Rosslyn Data Technologies PLC (RDT:LON), 1.8 | Petards Group plc (PEG:LON), 9.5 | Petards Group plc (PEG:LON), 9.5 | Novacyt SAS (NCYT:LON), 42.2 | Neometals Ltd (NMT:ASX), 0 | Neometals Ltd (NMT:ASX), 0 | Kromek Group Plc (KMK:LON), 8.8 | Jadestone Energy PLC (JSE:LON), 33.5 | Tissue Regenix Group plc (LSW:STU), 0
- Published:
25 Jan 2024 - Author:
-
Pages:
2 -
25th January 2024
@HybridanLLP
Status of this Note and Disclaimer
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment obje ....